1. Home
  2. MXCT vs INTT Comparison

MXCT vs INTT Comparison

Compare MXCT & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

SELL

Current Price

$1.45

Market Cap

136.2M

Sector

Health Care

ML Signal

SELL

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$12.91

Market Cap

148.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXCT
INTT
Founded
1999
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
136.2M
148.4M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
MXCT
INTT
Price
$1.45
$12.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$4.11
★ $20.00
AVG Volume (30 Days)
★ 1.1M
107.5K
Earning Date
11-10-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.06
Revenue
$33,026,000.00
★ $66,801,000.00
Revenue This Year
N/A
$22.35
Revenue Next Year
$15.53
$7.07
P/E Ratio
★ N/A
$231.67
Revenue Growth
N/A
★ 66.06
52 Week Low
$0.64
$7.07
52 Week High
$1.81
$20.00

Technical Indicators

Market Signals
Indicator
MXCT
INTT
Relative Strength Index (RSI) 69.59 49.19
Support Level $1.15 $12.71
Resistance Level $1.54 $15.25
Average True Range (ATR) 0.07 0.90
MACD 0.05 -0.09
Stochastic Oscillator 85.69 26.22

Price Performance

Historical Comparison
MXCT
INTT

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

Share on Social Networks: